Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease

scientific article published on 11 February 2016

Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1018122093
P356DOI10.1038/SREP20855
P2888exact matchhttps://scigraph.springernature.com/pub.10.1038/srep20855
P932PMC publication ID4749988
P698PubMed publication ID26865350
P5875ResearchGate publication ID294284091

P50authorKaoru SakataniQ57016404
P2093author name stringHiroyuki Arai
Kazuo Tsubota
Tetsuya Kawakita
Miki Uchino
Ikuko Toda
Kazumi Fukagawa
Mari Tanaka
Kenichi Yoshino
Seiichiro Hata
Seika Shimazaki
Takashi Okano
P2860cites workVisual fatigue and occupational stress in VDT operatorsQ23917921
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodiesQ24646616
Psychological factors and visual fatigue in working with video display terminalsQ24670194
Diagnostic tests in the Sicca syndromeQ70112003
Practical double vital staining for ocular surface evaluationQ72089084
Ocular fatigue is the major symptom of dry eyeQ72906255
Sjögren's syndromeQ75219081
Tear dynamics and dry eyeQ77429291
Anti-inflammatory therapy of dry eyeQ79317939
Protective Effect ofd-β-Hydroxybutyrate on Corneal Epithelia in Dry Eye Conditions through Suppression of ApoptosisQ33194215
Autologous serum eye drops for the treatment of dry eye diseasesQ34013889
Sodium hyaluronate eyedrops in the treatment of dry eyesQ34368785
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 yearsQ34443357
Epidemiology of dry eye syndrome.Q35076489
Treatment of dry eye by autologous serum application in Sjögren's syndromeQ35309629
A review of the Schirmer test for tear productionQ35385802
Regulatory pathways in lacrimal gland epitheliumQ35624258
D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson diseaseQ35919815
D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's diseaseQ36976707
Advances in understanding and managing dry eye diseaseQ37206550
Corneal injuriesQ39631416
Tear physiology and dry eyesQ39709731
Physiological roles of ketone bodies as substrates and signals in mammalian tissuesQ40280929
Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study GroupQ40765221
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.Q40948258
Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye.Q42684410
Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemiaQ44040992
Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host diseaseQ44401535
D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging boardQ46568367
Autologous serum eye drops for dry eye after LASIK.Q46920180
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
multicenter clinical trialQ6934595
P304page(s)20855
P577publication date2016-02-11
P1433published inScientific ReportsQ2261792
P1476titleRandomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease
P478volume6

Reverse relations

Q41189285Caloric restriction promotes cell survival in a mouse model of normal tension glaucomacites workP2860

Search more.